(Q39807777)

14 September 2017

title

TNF: a tumor-suppressing factor or a tumor-promoting factor? (English)

1 reference

14 September 2017

0 references

1

1 reference

14 September 2017

Christian Joffroy

2

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

6

1 reference

14 September 2017

issue

12

1 reference

14 September 2017

page(s)

1833-1836

1 reference

Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.155

Drosophila models for cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.155

Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.155

TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.155

von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.155

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.155

Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.155

New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.155

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.155

Malignancy and biologic therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.155

21 January 2018

Identifiers

DOI

10.2217/FON.10.155

1 reference

release_ooe5g6d2m5cbbpambprualc7jm

14 September 2017

Fatcat ID

0 references

1 reference